| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 119.26B | 115.59B | 108.28B | 103.61B | 93.74B |
| Gross Profit | 35.63B | 32.79B | 31.03B | 29.42B | 27.66B |
| EBITDA | 15.00B | 13.56B | 13.44B | 12.63B | 11.77B |
| Net Income | 10.57B | 1.50B | 6.18B | 5.72B | 1.21B |
Balance Sheet | |||||
| Total Assets | 131.89B | 120.69B | 125.62B | 118.97B | 116.38B |
| Cash, Cash Equivalents and Short-Term Investments | 21.71B | 17.71B | 17.93B | 16.77B | 18.84B |
| Total Debt | 5.23B | 8.68B | 9.21B | 12.98B | 15.39B |
| Total Liabilities | 39.02B | 38.19B | 40.11B | 40.95B | 43.95B |
| Stockholders Equity | 92.61B | 82.13B | 85.16B | 77.66B | 72.13B |
Cash Flow | |||||
| Free Cash Flow | 10.86B | 6.50B | 9.94B | 4.19B | 6.12B |
| Operating Cash Flow | 15.59B | 10.76B | 14.06B | 7.71B | 9.59B |
| Investing Cash Flow | -3.70B | -4.19B | -4.74B | -3.98B | -534.00M |
| Financing Cash Flow | -8.59B | -6.91B | -8.96B | -6.43B | -9.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥278.12B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
78 Outperform | ¥94.24B | 7.87 | ― | 3.82% | 3.17% | 654.02% | |
76 Outperform | ¥93.47B | 0.96 | ― | 1.43% | 8.02% | 1762.59% | |
73 Outperform | ¥222.73B | 18.03 | ― | 2.50% | 2.57% | 9.10% | |
71 Outperform | ¥107.86B | 15.48 | ― | 4.64% | 1.98% | -17.68% | |
69 Neutral | ¥133.69B | 15.63 | ― | 3.77% | -2.59% | 9.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |